Editorial |
Correspondence to Masao Endoh, MD, Department of Pharmacology, Yamagata University School of Medicine, 2-2, 2-chome, Iida-nishi, Yamagata 990-9585, Japan.
Key Words: Ca2+ myocardial contractility myocardial cell troponin C
Binding of intracellular Ca2+ ions to troponin C subsequent to membrane excitation triggers the interaction of actin with myosin molecules by displacing the inhibition induced by troponin I at diastolic levels of [Ca2+]i. Therefore, in intact myocardial cells, the amplitude and rate of tension development and relaxation are primarily determined by the rate of Ca2+ mobilization and deprivation, by the crossbridge cycling rate, or by the contribution of both. From this perspective, there are 3 general types of mechanisms by which it should be possible to alter the contractile performance of cardiac muscle. Binding of Ca2+ to troponin C plays a key role and is considered to be the central mechanism of cardiac excitation-contraction coupling. The regulation of the Ca2+ mobilizing process is regarded as the upstream mechanism; the process subsequent to Ca2+ binding to troponin C (ie, an alteration of the response of the myofilaments to a given level of occupancy of Ca2+ binding sites on troponin C) is regarded as the downstream mechanism.1
The mechanistic analysis of the role of Ca2+ ions
in the cardiac contractile regulation in intact myocardial cells has
progressed significantly since the introduction of methods to apply the
Ca2+-sensitive photoprotein (aequorin) and
fluorescent dyes (eg, fura-2, indo-1, and fluo-3) in intact
myocardial cells.2 3 4 The majority of inotropic
interventions alter the intracellular Ca2+ transient. The
increase in frequency of contraction (force-frequency relationship) and
cardiotonic agents, such as ß-adrenoceptor agonists, digitalis, and
phosphodiesterase III inhibitors, act primarily through the
upstream mechanism. By contrast, length-dependent regulation
(Frank-Starling mechanism), activation of receptors coupled to the
stimulation of phosphoinositide hydrolysis
(
-adrenoceptors, endothelin, and angiotensin
AT2 receptors), and actions of novel Ca2+
sensitizers (eg, EMD 57033 and Org 30029) are associated with a
relatively small alteration or no alteration in Ca2+
transients. These are postulated to act through the central and/or
downstream mechanism. The upstream mechanism can be easily
distinguished from the other 2 mechanisms by examination of the
relationship between the amplitude of the Ca2+ transient
and the force developed in twitch contraction or by an analysis
of the steady-state tension-pCa relationship during application of
tetanic stimulation in the presence of a dysfunction of the cardiac
sarcoplasmic reticular Ca2+ pump induced by ryanodine or
thapsigargin in intact myocardial cells loaded with Ca2+
indicators.3 4 Application of these experimental
procedures to analysis of the downstream mechanism, however, is
difficult and limited. It is evident that the downstream mechanism
includes 2 processes: (1) the interaction of the troponin-tropomyosin
complex with actin and (2) crossbridge cycling itself. The combination
of the in vitro motility assay, in which the movement of visualized
thin filaments or actin molecules over a fixed layer of myosin can be
directly investigated, the 45Ca2+-binding
assay, and the force-pCa relationship in cardiac skinned fibers
differentiates the 2 processes. The first process shifts the force-pCa
curve to the left in skinned fibers but does not increase the amount of
45Ca2+ binding to troponin C and requires the
troponin-tropomyosin complex for regulation in the in vitro motility
assay, whereas the second process does not require the
complex.3 4
In this issue of Circulation Research, Palmer and
Kentish5 have elegantly characterized the crossbridge
cycling rate after isolation of the downstream mechanism from the
central mechanism by application of caged compounds to skinned cardiac
fibers isolated from rat and guinea pig ventricular
trabeculae. The force-pCa relationships for both species
were sigmoidal, fitted by the Hill equation, and superimposable, an
indication that the myofibrillar Ca2+ sensitivity
(Ca2+ binding affinity of troponin C) in the 2 species was
the same. Since the Ca2+ binding sites of troponin C could
be abruptly saturated by Ca2+ released from a caged
Ca2+ compound, NP-EGTA, by photolysis with application of
flash, the maximal rate of crossbridge cycling could be elicited in
skinned fibers from the rat and guinea pig under the same experimental
conditions. The former process of the downstream mechanism, ie,
modulation at the level of interaction of the troponin-tropomyosin
complex with actin could also be bypassed in the experiment of Palmer
and Kentish5 because no interventions that might have
potential action on this process were applied in their study. The rate
constant of Ca2+ activation of force
(kact) at the maximum flash energy in rat
trabeculae was 5-fold greater than that in guinea pig
trabeculae, indicating that rat trabeculae were
activated 5-fold faster than were trabeculae from
guinea pigs. Interestingly and importantly, the rate constant for force
redevelopment (ktr) after forcible detachment of
the crossbridges determined during maximal activation (pCa 4.5) in the
rat was also 4.5-fold greater than that in the guinea pig, and these
values were not significantly different from the maximum values of
kact measured in the respective species. This
indicates that the different kact values in the
2 species apparently reflect the relative rates of the force-generating
processes. It is important to note that kact was
measured after sudden alteration of [Ca2+], whereas
ktr, which reflects the rate of crossbridge
reattachment and transition to force-generating states, was determined
under constant activation by Ca2+, thus bypassing any
direct influence of [Ca2+] on the rate at which
Ca2+ ions trigger conformational changes in the regulatory
proteins of the thin filament. The consistency of these 2
values provides strong support for the correctness of the experimental
procedure to produce an immediate elevation of
[Ca2+]i by means of photolysis of a caged
Ca2+ compound in skinned cardiac fibers. Under such
conditions, the authors have clearly demonstrated that the maximum rate
of Ca2+-activated force development is limited by
the rate at which detached or weakly bound crossbridges enter the
force-generating state (downstream mechanism) rather than by the rate
at which the thin filament is switched on by Ca2+ binding
to troponin C (central mechanism). It has been known that the
distribution of myosin isozymes involves a wide range of variation
among mammalian species. The rat ventricle contains mostly
V1 myosin (
myosin heavy chains), whereas
V2 and V3 myosins (
ß and ßß heavy
chains) predominate in the guinea pig. In various biochemical and
mechanical assays, crossbridges containing V1 myosin have a
2- to 6-fold higher cycling rate compared with those containing
V3 myosin, which may explain, in large part, the faster
activation rates in the rat compared with the guinea pig. Since the
human ventricle contains mostly V3 myosins,
analysis of the similarity and dissimilarity by comparison with
these species by means of the methods of Palmer and
Kentish5 may shed light on the regulation in human
ventricular muscle. In this context, it is also noteworthy
that the comparison of unitary displacements and forces between
V1 and V3 myosin by means of optical trap
techniques in the in vitro motility assay revealed that both the
unitary displacements and forces of the 2 myosin isoforms are similar
in amplitude but different in duration.6
The above consideration also accounts for the difference in the rate of relaxation between the rat and the guinea pig. The kact values in the 2 species were not significantly different from the corresponding maximum rates of relaxation determined by a sudden drop of solution [Ca2+] by use of flash photolysis of diazo-2, a caged chelator of Ca2+. The rate of myocardial relaxation may be determined either by the rate at which Ca2+ dissociates from troponin C (koff) and causes thin filament deactivation (central mechanism) or by the net rate at which myosin crossbridges detach from actin once Ca2+ ions are lost from troponin C (downstream mechanism). The similarity of the force-pCa relationships in the rat and guinea pig implies that koff should be equivalent in both species. Thus, the 5-fold difference in relaxation rate between the 2 species suggests that the relaxation rate caused by photolysis of diazo-2 may reflect the detachment rate of crossbridges themselves but not koff, which may be due to the difference between the myosin isozyme composition in the 2 species.5
Palmer and Kentish5 are the first to carry out a careful comparison of the rate of relaxation with kact or ktr under the same experimental conditions and in the same animal species. The rate of relaxation was similar to kact or ktr in a given species. These findings do not fit the crossbridge cycling model for skeletal muscle proposed previously7 : in the kinetic model, the rate of relaxation, which occurs at lower [Ca2+]i than activation, should be lower than kact or ktr (see Palmer and Kentish5 for detailed discussion). The authors, therefore, postulated that during relaxation crossbridges may subsequently lose force by reversal of the force-generating transition (crossbridge working stroke) rather than by the slower forward detachment step.5 The fact that kact is consistent with ktr provides strong support for the conclusion that the kact determined by the photolysis may reflect accurately the true rate of activation of crossbridges under the experimental conditions. In addition, the mode of dependence of kact and ktr on the extent of contractile activation corresponds with the activation dependence of the crossbridge cycling rate in the current concept of cardiac excitation-contraction coupling. On the other hand, the rate of relaxation solely determined by means of photolysis of the caged Ca2+-chelating compound diazo-2 may likely involve yet-unknown factors that contribute to the overestimation of the rate of relaxation in skinned cardiac fibers and also to the difference in relaxation kinetics between the rat (double exponential) and the guinea pig (single exponential).5 Simnett and coworkers8 9 have reported an even lower rate constant of activation (7.15 s-1) than of relaxation (15.4 s-1), determined by photolysis of nitr-5 and diazo-2, respectively, at 12°C. Further study focusing on the factors contributing to the rate of relaxation, including the development of this new experimental model in cardiac muscle as proposed by the authors,5 should be pursued.
Increasing interest has been focused on the elucidation of the basis of the downstream mechanism and its regulation by cardiotonic agents, because the downstream mechanism may bypass the risk of Ca2+ overload that leads to arrhythmias, myocardial cell injury, and energetic disadvantages that are associated with cardiotonic agents acting through the upstream mechanism. Furthermore, they may be effective in regulating force even under pathophysiological conditions such as acidosis and myocardial stunning. It has already been demonstrated that the actions of Ca2+ sensitizers acting primarily on the downstream mechanism reveal different characteristics among the compounds in respect to regulation of the rate of activation and detachment of crossbridges. EMD 57033 increased preferentially the rate of activation and accelerated slightly the rate of relaxation in skinned guinea pig cardiac trabeculae.8 9 In the rat cardiac skinned fibers loaded with diazo-2, CGP 48506 did not affect the rate of relaxation, whereas caffeine accelerated the relaxation rate.10 A potential and serious disadvantage accompanied by the action of Ca2+ sensitizers is an impairment of relaxation that may lead to diastolic dysfunction in the clinical setting. In contrast to EMD 57033, levosimendan did not impair the relaxation in intact myocardial cells.11 In this respect, the experimental procedure to produce a rapid alteration of [Ca2+] by means of the photolysis of caged compounds in skinned cardiac fibers is important for elucidation of the mechanism of action of Ca2+ sensitizers, which may provide useful information for the clinical application of these agents as well as for analysis of basic molecular mechanisms of cardiac muscle contraction.
Footnotes
The opinions expressed in this article are not necessarily those of the editor or of the American Heart Association.
References
1. Blinks JR, Endoh M. Modification of myofibrillar responsiveness to Ca++ as an inotropic mechanism. Circulation. 1986;73(Suppl III):III-85III-98.
2. Blinks JR, Wier WG, Hess P, Prendergast FG. Measurement of Ca2+ concentrations in living cells. Prog Biophys Mol Biol.. 1982;40:1114.[Medline] [Order article via Infotrieve]
3. Endoh M. Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells. Jpn Heart J.. 1998;39:144.[Medline] [Order article via Infotrieve]
4. Kurihara S. Regulation of cardiac contraction by intracellular Ca2+. Jpn J Physiol.. 1994;44:591611.[Medline] [Order article via Infotrieve]
5.
Palmer S, Kentish JC. Roles of Ca2+ and
crossbridge kinetics in determining the maximum rates of
Ca2+ activation and relaxation in rat and guinea pig
skinned trabeculae. Circ Res.. 1998;83:179186.
6.
Sugiura S, Kobayakawa N, Fujita H, Yamashita H,
Momomura S, Chaen S, Omata M, Sugi H. Comparison of unitary
displacements and forces between 2 cardiac myosin isoforms by the
optical trap technique: molecular basis for cardiac adaptation.
Circ Res.. 1998;82:10291034.
7.
Brenner B. Effect of Ca2+ on crossbridge
turnover kinetics in skinned single rabbit psoas fibers: implications
for regulation of muscle contraction. Proc Natl Acad Sci
U S A.. 1988;85:32653269.
8. Simnett SJ, Lipscomb S, Ashley CC, Mulligan IP. The effect of EMD 57033, a novel cardiotonic agent, on the relaxation of skinned cardiac and skeletal muscle produced by photolysis of diazo-2, a caged calcium chelator. Pflugers Arch.. 1993;425:175177.[Medline] [Order article via Infotrieve]
9. Simnett SJ, Lipscomb S, Ashley CC, Potter JD, Mulligan IP. The thiadiazinone EMD 57033 speeds the activation of skinned cardiac muscle produced by photolysis of nitr-5. Pflugers Arch.. 1994;427:550552.[Medline] [Order article via Infotrieve]
10.
Palmer S, Kentish JC. Differential effects of
Ca2+ sensitizers caffeine and CGP 48506 on the relaxation
rate of rat skinned cardiac trabeculae. Circ
Res.. 1997;80:682687.
11. Sato S, Talukder MAH, Sugawara H, Sawada H, Endoh M. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit. J Mol Cell Cardiol.. 1998;30:11151128.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. S. Rhodes, K. M. Ropella, S. H. Audi, A. K. S. Camara, L. G. Kevin, P. S. Pagel, and D. F. Stowe Cross-bridge kinetics modeled from myoplasmic [Ca2+] and LV pressure at 17{degrees}C and after 37{degrees}C and 17{degrees}C ischemia Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1217 - H1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. deChatel, O. Vuolteenaho, and H. Ruskoaho Endothelin-1 Contributes to the Frank-Starling Response in Hypertrophic Rat Hearts Hypertension, January 1, 2003; 41(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Szokodi, P. Tavi, G. Foldes, S. Voutilainen-Myllyla, M. Ilves, H. Tokola, S. Pikkarainen, J. Piuhola, J. Rysa, M. Toth, et al. Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility Circ. Res., September 6, 2002; 91(5): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Moss Plasticity in the Dynamics of Myocardial Contraction : Ca2+, Crossbridge Kinetics, or Molecular Cooperation Circ. Res., April 16, 1999; 84(7): 862 - 865. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |